Evidence map›Paper›PMID 20368355›Full record

ArticleMolecular and cellular biology2010

EKLF directly activates the p21WAF1/CIP1 gene by proximal promoter and novel intronic regulatory regions during erythroid differentiation.

Miroslawa Siatecka, Felix Lohmann, Sujin Bao, James J Bieker

Abstract read
In one paragraph

Article in Molecular and cellular biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. AMolecular and cellular biology · 2020
    Article
  6. Article
  7. Dlx5 and Dlx6 can antagonize cell division at the GBMC molecular and cell biology · 2019
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Miroslawa SiateckaMount Sinai School of Medicine, Department of Developmental and Regenerative Biology, Box 1020, One Gustave Levy Place, New York, NY 10029, USA.
Felix Lohmann
Sujin Bao
James J Bieker
Icahn School of Medicine at Mount Sinai · US

Funding

Function of Putative Determinant in HematopoiesisR01DK046865 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI JAMES J BIEKER · 1993 to 2026
$11.2M
NIDDK NIH HHS R01 DK046865NIDDK NIH HHS R01 DK46865
6 · The paper itself

Abstract

The switch from proliferation to differentiation during the terminal stages of erythropoiesis is a tightly controlled process that relies in part on transcription factor-mediated activation of cell cycle components. EKLF is a key transcription factor that is necessary for the initial establishment of the red cell phenotype. Here, we find that EKLF also plays a role during the subsequent differentiation process, as it induces p21(WAF1/CIP1) expression independent of p53 to regulate the changes in the cell cycle underlying erythroid maturation. EKLF activates p21 not only by directly binding to an EKLF site within a previously characterized GC-rich region in the p21 proximal promoter but also by occupancy at a novel, phylogenetically conserved region that contains consensus CACCC core motifs located downstream from the p21 TATA box. Our findings demonstrate that EKLF, likely in coordination with other transcription factors, directly contributes to the complex set of events that occur at the final erythroid cell divisions and accentuates terminal differentiation directly by activation of CDK inhibitors such as p21.

Indexed as

IntronsPromoter Regions, GeneticRegulatory Sequences, Nucleic AcidAnimalsBase SequenceCell CycleCell DifferentiationCell LineCyclin-Dependent Kinase Inhibitor p21Erythroid CellsGene Expression Regulation, DevelopmentalHumansKruppel-Like Transcription FactorsMiceMolecular Sequence DataSequence AlignmentCyclin-Dependent Kinase Inhibitor p21erythroid Kruppel-like factorKruppel-Like Transcription Factors

Identifiers

PMID20368355
PMCPMC2876526
OpenAlexW2080972100

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.